Yahoo Web Search

  1. Ads
    related to breast cancer
  1. Yahoo Finance Results

  2. There was some fabulous research news for women with breast cancer earlier this summer: 70% of women with early stage disease who often get chemotherapy under current treatment ...

  3. Puma Biotech Gets EU Nod for Breast Cancer Drug Nerlynx

    Zacks via Yahoo FinanceSep 06 15:09 PM

    The drug has been approved as an extended adjuvant treatment of early stage hormone receptor positive (HER2-positive) breast cancer in patients, previously treated with Roche’s ...

  4. A month has gone by since the last earnings report for Radius Health (RDUS). Will the recent negative trend continue leading up to its next earnings release, or is Radius Health due for a breakout ...

  5. Stocks of big pharmaceutical companies have been on a tear lately -- the SPDR S&P Pharmaceuticals ETF (NYSEMKT: XPH) is up 15% since the beginning up the year, compared with 8.5% gains for the ...

  6. The major pipeline and regulatory updates in the biotech sector over the past week included Amgen AMGN’s Blincyto getting EC approval for a label expansion and Puma Biotechnology PBYI winning EC approval for Nerlynx.

  7. Further, U.S. invasive breast cancer revenues grew 13% year over year. Notably, the company witnessed quarterly test volume growth of 4%. This beat the growth of 3% recorded in 2017.

  8. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Amgen AMGN, Puma Biotechnology ...

  9. In clinical studies, strong results were achieved by Lynparza in first-line ovarian cancer while Imfinzi showed an overall-survival benefit for patients in earlier-stage lung cancer ...

  10. Lab test may identify dangerous gene mutations, study finds

    Associated Press via Yahoo FinanceSep 12 21:29 PM

    Researchers used genetic engineering to create thousands of tiny variations in a gene linked to breast cancer, and tested each one in a lab to predict whether it would promote ...

  11. Edited Transcript of IMMU earnings conference call or presentation 23-Aug-18 9:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceSep 06 20:17 PM

    Post ASCO, we successfully raised net proceeds of approximately $300 million through a June equity offering. Our stable cash position allows us to build out our commercial...

  1. Ads
    related to breast cancer